Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2023-06-21 | Reverse | 1:10 |
Cypherpunk Technologies Inc. is a biopharmaceutical firm developing antibody therapies for cancer, including DKN-01 and FL-501, with ongoing clinical trials and licensing agreements, based in Cambridge, MA.

Cypherpunk Technologies focuses on its digital asset treasury strategy by acquiring and holding Zcash (ZEC) to build long-term shareholder value through appreciation and ecosystem participation.
Overall rating: B
| PEER | PRICE | |
|---|---|---|
APLM | $23.42 | COMPARE |
BCTX | $4.21 | COMPARE |
DARE | $0.78 | COMPARE |
ICU | $3.54 | COMPARE |
CTXR | $0.60 | COMPARE |
PCSA | $1.96 | COMPARE |
CRIS | $1.00 | COMPARE |
ASBP | $8.54 | COMPARE |